B Lymphocyte Stimulator-specific Inhibitor [EPC]

B Lymphocyte Stimulator-specific Inhibitor [EPC] was reported 32030 times

Drugs of the B Lymphocyte Stimulator-specific Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTINUCLEAR ANTIBODY NEGATIVE 17 0.4857
1 LUPUS ENTERITIS 19 0.3220
2 SLE ARTHRITIS 85 0.2993
3 PERICARDITIS LUPUS 11 0.2750
4 LUPUS PNEUMONITIS 26 0.2321
5 LUPUS NEPHRITIS 420 0.2244
6 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 25 0.2000
7 LUPUS ENDOCARDITIS 12 0.1967
8 CENTRAL NERVOUS SYSTEM LUPUS 43 0.1928
9 COMPLEMENT FACTOR INCREASED 14 0.1667
10 DOUBLE STRANDED DNA ANTIBODY POSITIVE 37 0.1135
11 SYSTEMIC LUPUS ERYTHEMATOSUS 3979 0.1120
12 LUPUS VASCULITIS 12 0.1111
13 NEUROPSYCHIATRIC LUPUS 13 0.1074
14 COMPLEMENT FACTOR DECREASED 18 0.1006
15 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 77 0.0965
16 HYPOCOMPLEMENTAEMIA 13 0.0769
17 MENINGITIS MENINGOCOCCAL 12 0.0706
18 BUTTERFLY RASH 64 0.0631
19 NEUTROPHIL COUNT 13 0.0619
20 PRODUCT COMPLAINT 1411 0.0556
21 COMPLEMENT FACTOR C3 DECREASED 11 0.0451
22 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 20 0.0436
23 DISCONTINUED PRODUCT ADMINISTERED 14 0.0426
24 HERPES ZOSTER CUTANEOUS DISSEMINATED 10 0.0426
25 HERPES SIMPLEX REACTIVATION 16 0.0420
26 EXPOSURE VIA SKIN CONTACT 1029 0.0397
27 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 13 0.0358
28 BIOPSY KIDNEY 10 0.0351
29 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1635 0.0350
30 MIXED CONNECTIVE TISSUE DISEASE 13 0.0310
31 VEIN COLLAPSE 20 0.0260
32 BLOOD CHOLESTEROL 12 0.0253
33 CORONAVIRUS TEST POSITIVE 25 0.0243
34 INJECTION SITE DRYNESS 21 0.0232
35 ANTIPHOSPHOLIPID SYNDROME 37 0.0230
36 CUTANEOUS LUPUS ERYTHEMATOSUS 44 0.0226
37 SEROSITIS 12 0.0217
38 SOCIAL PROBLEM 87 0.0210
39 PAROTID GLAND ENLARGEMENT 13 0.0199
40 INJECTION SITE EXFOLIATION 13 0.0195
41 PRODUCT DOSE OMISSION ISSUE 5154 0.0175
42 PLEURITIC PAIN 47 0.0170
43 BLOOD IMMUNOGLOBULIN M DECREASED 16 0.0160
44 BLOOD ALBUMIN INCREASED 13 0.0146
45 IMMUNOGLOBULINS DECREASED 20 0.0146
46 UTERINE DILATION AND CURETTAGE 13 0.0144
47 NEPHRITIS 47 0.0141
48 SKIN INDURATION 29 0.0140
49 LIVE BIRTH 112 0.0134
50 ANTIBIOTIC THERAPY 13 0.0133
51 PRODUCT STORAGE ISSUE 50 0.0132
52 PHARYNGEAL INFLAMMATION 16 0.0132
53 CORONAVIRUS INFECTION 83 0.0125
54 JC VIRUS INFECTION 20 0.0125
55 COMPLEX REGIONAL PAIN SYNDROME 18 0.0122
56 DENGUE FEVER 27 0.0118
57 URINE ABNORMALITY 52 0.0114
58 PATIENT DISSATISFACTION WITH TREATMENT 22 0.0114
59 GASTRITIS HAEMORRHAGIC 17 0.0114
60 PROTEIN URINE PRESENT 55 0.0110
61 VEIN DISORDER 55 0.0110
62 PROTEINURIA 207 0.0109
63 VACCINATION FAILURE 18 0.0108
64 NASAL ULCER 17 0.0107
65 OPHTHALMIC HERPES ZOSTER 19 0.0105
66 SYMPTOM RECURRENCE 62 0.0104
67 CALCINOSIS 23 0.0103
68 ACCIDENTAL EXPOSURE TO PRODUCT 1058 0.0103
69 VEIN RUPTURE 17 0.0101
70 UPPER RESPIRATORY TRACT INFLAMMATION 12 0.0100
71 PRODUCT DOSE OMISSION 651 0.0100
72 DRUG EXPOSURE BEFORE PREGNANCY 10 0.0099
73 PLEURISY 58 0.0098
74 POST HERPETIC NEURALGIA 14 0.0097
75 METABOLIC SURGERY 11 0.0097
76 INCORRECT DISPOSAL OF PRODUCT 29 0.0089
77 B-LYMPHOCYTE COUNT DECREASED 12 0.0088
78 CEREBROSPINAL FLUID LEAKAGE 16 0.0087
79 ASTIGMATISM 13 0.0086
80 PRODUCT STORAGE ERROR 750 0.0086
81 POLYARTHRITIS 45 0.0085
82 DENTAL OPERATION 21 0.0085
83 BLOOD IMMUNOGLOBULIN G DECREASED 21 0.0085
84 EXPOSURE DURING PREGNANCY 525 0.0084
85 VARICOSE VEIN 43 0.0083
86 ENDODONTIC PROCEDURE 21 0.0083
87 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 65 0.0079
88 MEAN CELL HAEMOGLOBIN INCREASED 13 0.0078
89 H1N1 INFLUENZA 11 0.0078
90 VASCULITIS 90 0.0077
91 SALMONELLOSIS 13 0.0077
92 FOOT OPERATION 37 0.0075
93 PRODUCT PREPARATION ISSUE 49 0.0075
94 PAINFUL RESPIRATION 18 0.0075
95 MYASTHENIA GRAVIS CRISIS 11 0.0074
96 MULTIPLE ALLERGIES 58 0.0074
97 UNDERDOSE 538 0.0074
98 HYPERPARATHYROIDISM SECONDARY 18 0.0072
99 LIMB OPERATION 34 0.0071
100 SKIN WOUND 12 0.0071
101 ENTERITIS INFECTIOUS 12 0.0070
102 NEPHROTIC SYNDROME 48 0.0070
103 DECREASED IMMUNE RESPONSIVENESS 68 0.0069
104 ANKLE OPERATION 10 0.0068
105 ANTINUCLEAR ANTIBODY POSITIVE 22 0.0068
106 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 12 0.0067
107 BRAIN FOG 105 0.0067
108 INJECTION SITE HAEMORRHAGE 535 0.0067
109 NONSPECIFIC REACTION 36 0.0066
110 PULMONARY PAIN 19 0.0065
111 TYPE 1 DIABETES MELLITUS 39 0.0065
112 HYSTERECTOMY 56 0.0065
113 DEVICE INFUSION ISSUE 16 0.0064
114 NECK SURGERY 15 0.0064
115 PRODUCT AVAILABILITY ISSUE 144 0.0063
116 MASTECTOMY 11 0.0063
117 ANXIETY DISORDER 21 0.0063
118 PREMATURE RUPTURE OF MEMBRANES 15 0.0062
119 PRODUCT SUPPLY ISSUE 44 0.0062
120 THERAPY CESSATION 310 0.0060
121 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 202 0.0060
122 KIDNEY INFECTION 117 0.0060
123 SURGERY 349 0.0059
124 DRUG EFFECT LESS THAN EXPECTED 88 0.0059
125 ILL-DEFINED DISORDER 356 0.0059
126 DISSEMINATED TUBERCULOSIS 15 0.0058
127 VARICELLA ZOSTER VIRUS INFECTION 12 0.0058
128 HYPOGAMMAGLOBULINAEMIA 38 0.0058
129 PERICARDITIS 96 0.0057
130 DEPRESSIVE SYMPTOM 20 0.0057
131 SHOULDER OPERATION 24 0.0056
132 EMERGENCY CARE 17 0.0056
133 NOCARDIOSIS 14 0.0055
134 VIRAL UPPER RESPIRATORY TRACT INFECTION 26 0.0055
135 TOOTH INFECTION 72 0.0055
136 COLONOSCOPY 12 0.0054
137 ILLNESS 561 0.0054
138 MENOPAUSE 14 0.0054
139 THERAPY INTERRUPTED 380 0.0053
140 IMMUNE SYSTEM DISORDER 70 0.0053
141 GLOMERULAR FILTRATION RATE DECREASED 65 0.0053
142 DEVICE USE ERROR 181 0.0052
143 CD4 LYMPHOCYTES DECREASED 11 0.0051
144 INABILITY TO AFFORD MEDICATION 50 0.0050
145 WALKING AID USER 33 0.0050
146 BLOOD CHOLESTEROL ABNORMAL 23 0.0050
147 PERIARTHRITIS 11 0.0048
148 KNEE OPERATION 47 0.0048
149 GALLBLADDER OPERATION 19 0.0047
150 HERPES VIRUS INFECTION 27 0.0047
151 ATYPICAL PNEUMONIA 14 0.0047
152 INJECTION SITE BRUISING 372 0.0047
153 IMMUNOSUPPRESSION 41 0.0046
154 INFUSION SITE BRUISING 10 0.0046
155 PNEUMOCYSTIS JIROVECII PNEUMONIA 46 0.0046
156 CERVICAL DYSPLASIA 10 0.0046
157 ERYSIPELAS 23 0.0046
158 HYPERSENSITIVITY VASCULITIS 12 0.0046
159 MIGRAINE 432 0.0045
160 INJECTION SITE PAIN 1388 0.0045
161 GLOMERULONEPHRITIS 11 0.0045
162 UPPER RESPIRATORY TRACT CONGESTION 13 0.0045
163 HERPES ZOSTER 258 0.0045
164 PRODUCT DISTRIBUTION ISSUE 41 0.0044
165 ENERGY INCREASED 26 0.0044
166 BRAIN OPERATION 10 0.0044
167 HIP ARTHROPLASTY 67 0.0044
168 PHARYNGITIS 54 0.0043
169 DISCOURAGEMENT 10 0.0043
170 BEDRIDDEN 56 0.0043
171 HIP SURGERY 23 0.0042
172 NEAR DEATH EXPERIENCE 14 0.0042
173 RHINITIS 34 0.0042
174 PULMONARY TUBERCULOSIS 18 0.0042
175 INFLAMMATION 214 0.0041
176 ANIMAL BITE 11 0.0041
177 MYCOBACTERIUM AVIUM COMPLEX INFECTION 11 0.0041
178 INFLUENZA 457 0.0041
179 BLADDER PAIN 13 0.0041
180 SHOULDER ARTHROPLASTY 11 0.0041
181 SPINAL OPERATION 50 0.0041
182 RENAL PAIN 43 0.0041
183 MIGRAINE WITH AURA 11 0.0040
184 INFUSION SITE PAIN 52 0.0040
185 RHINALGIA 11 0.0040
186 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 30 0.0040
187 FIBROMYALGIA 97 0.0040
188 CENTRAL VENOUS CATHETERISATION 12 0.0040
189 LYMPHOPENIA 56 0.0040
190 TOOTH EXTRACTION 49 0.0039
191 GASTRIC INFECTION 15 0.0039
192 LEUKOPENIA 196 0.0039
193 MENINGITIS 26 0.0039
194 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 701 0.0039
195 EXFOLIATIVE RASH 10 0.0038
196 HOSPITALISATION 583 0.0038
197 WEIGHT FLUCTUATION 39 0.0037
198 SARS-COV-2 TEST POSITIVE 49 0.0037
199 CHEMOTHERAPY 14 0.0037
200 IMMUNODEFICIENCY 55 0.0037
201 HEAD DISCOMFORT 65 0.0037
202 ARTHRITIS BACTERIAL 15 0.0037
203 PHOTOSENSITIVITY REACTION 60 0.0036
204 OROPHARYNGEAL PAIN 336 0.0036
205 INJECTION SITE INJURY 20 0.0036
206 CARDIAC OPERATION 31 0.0036
207 PHARYNGITIS STREPTOCOCCAL 39 0.0036
208 JOINT DISLOCATION 38 0.0036
209 URINARY TRACT INFECTION 612 0.0036
210 FACIAL PAIN 32 0.0036
211 RENAL DISORDER 166 0.0036
212 KNEE ARTHROPLASTY 75 0.0036
213 MOUTH ULCERATION 75 0.0036
214 UPPER RESPIRATORY TRACT INFECTION 164 0.0035
215 DYSLIPIDAEMIA 18 0.0035
216 RHINORRHOEA 229 0.0035
217 EYE INFECTION 40 0.0035
218 INSURANCE ISSUE 54 0.0035
219 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
220 INJECTION SITE RASH 108 0.0035
221 OESOPHAGEAL CANDIDIASIS 14 0.0035
222 AUTOIMMUNE DISORDER 34 0.0035
223 HEPATITIS B REACTIVATION 11 0.0035
224 SKIN DISORDER 115 0.0034
225 SKIN LESION 94 0.0034
226 ADVERSE DRUG REACTION 306 0.0034
227 INTENTIONAL DOSE OMISSION 97 0.0034
228 INFUSION SITE EXTRAVASATION 21 0.0034
229 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
230 JOINT STIFFNESS 88 0.0034
231 BRONCHITIS 248 0.0033
232 INFUSION SITE REACTION 10 0.0033
233 INFUSION SITE HAEMORRHAGE 11 0.0033
234 SUSPECTED COVID-19 11 0.0033
235 WOUND 93 0.0033
236 ORAL INFECTION 13 0.0033
237 ARTHRALGIA 1380 0.0033
238 SKIN INJURY 11 0.0033
239 INFECTION 479 0.0033
240 SINUSITIS 339 0.0033
241 ARTHRITIS 260 0.0033
242 CONDITION AGGRAVATED 1003 0.0033
243 DISABILITY 65 0.0033
244 SKIN WARM 19 0.0033
245 BLOOD PRESSURE DIASTOLIC INCREASED 15 0.0032
246 MALAISE 1425 0.0032
247 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
248 LARYNGEAL OEDEMA 20 0.0032
249 NEPHROLITHIASIS 148 0.0032
250 AUTOIMMUNE HAEMOLYTIC ANAEMIA 11 0.0032
251 SPINAL FUSION SURGERY 13 0.0032
252 PARAESTHESIA ORAL 46 0.0032
253 PROTEIN TOTAL DECREASED 12 0.0032
254 COVID-19 557 0.0032
255 THERAPEUTIC RESPONSE UNEXPECTED 142 0.0032
256 EAR INFECTION 84 0.0032
257 THYROID MASS 12 0.0031
258 CUSHINGOID 10 0.0031
259 INFUSION RELATED REACTION 205 0.0031
260 SWELLING 288 0.0031
261 CATARACT OPERATION 18 0.0030
262 SCLERODERMA 11 0.0030
263 LOW BIRTH WEIGHT BABY 24 0.0030
264 SKIN ULCER 78 0.0030
265 PERFORMANCE STATUS DECREASED 14 0.0030
266 ACCIDENTAL UNDERDOSE 42 0.0029
267 RESPIRATORY TRACT INFECTION 76 0.0029
268 NASOPHARYNGITIS 534 0.0029
269 PAIN 1776 0.0029
270 VIRAL INFECTION 96 0.0029
271 INFUSION SITE SWELLING 18 0.0029
272 OESOPHAGEAL DISORDER 11 0.0029
273 PERICARDIAL EFFUSION 66 0.0029
274 PYREXIA 986 0.0028
275 TOOTH ABSCESS 29 0.0028
276 FRUSTRATION TOLERANCE DECREASED 23 0.0028
277 DISEASE COMPLICATION 13 0.0028
278 CYTOMEGALOVIRUS INFECTION 47 0.0028
279 INFLAMMATORY MARKER INCREASED 14 0.0028
280 PULMONARY HAEMORRHAGE 22 0.0028
281 INTERCEPTED MEDICATION ERROR 13 0.0028
282 ROSACEA 13 0.0028
283 BLOOD TEST ABNORMAL 39 0.0028
284 LOCALISED INFECTION 67 0.0028
285 PIGMENTATION DISORDER 17 0.0028
286 INTRACRANIAL ANEURYSM 11 0.0027
287 PRE-ECLAMPSIA 13 0.0027
288 ORAL HERPES 53 0.0027
289 SUBCUTANEOUS ABSCESS 13 0.0027
290 ULCER 43 0.0027
291 JOINT SWELLING 325 0.0027
292 FATIGUE 2095 0.0027
293 VITAMIN D DECREASED 23 0.0027
294 LIP SWELLING 89 0.0027
295 CRYING 97 0.0027
296 PERIPHERAL SWELLING 410 0.0027
297 PRODUCTIVE COUGH 127 0.0027
298 PHARYNGEAL SWELLING 26 0.0027
299 OROPHARYNGEAL DISCOMFORT 24 0.0027
300 BLOOD ALBUMIN DECREASED 21 0.0026
301 AUTOIMMUNE THYROIDITIS 10 0.0026
302 INJECTION SITE VESICLES 16 0.0026
303 SWELLING FACE 172 0.0026
304 INJECTION SITE DISCOLOURATION 33 0.0026
305 ADVERSE REACTION 35 0.0026
306 PAIN IN EXTREMITY 776 0.0026
307 PRODUCT PRESCRIBING ISSUE 57 0.0026
308 HYPERSOMNIA 75 0.0026
309 DEPRESSION 594 0.0026
310 EYE OPERATION 12 0.0026
311 MOUTH SWELLING 15 0.0026
312 ABORTION SPONTANEOUS 104 0.0026
313 SINUS CONGESTION 35 0.0026
314 ABSCESS LIMB 11 0.0026
315 APHONIA 36 0.0026
316 PURULENT DISCHARGE 11 0.0026
317 NASAL CONGESTION 151 0.0026
318 APPENDICITIS 24 0.0026
319 CONTUSION 247 0.0026
320 CHEST PAIN 473 0.0026
321 PRODUCT DOSE OMISSION IN ERROR 72 0.0025
322 HEADACHE 1593 0.0025
323 PYELONEPHRITIS 22 0.0025
324 GASTROENTERITIS 37 0.0025
325 SPINAL DISORDER 24 0.0025
326 DRUG DOSE OMISSION 417 0.0025
327 LOCAL SWELLING 44 0.0025
328 EAR PAIN 49 0.0025
329 IMMOBILE 11 0.0025
330 POOR VENOUS ACCESS 26 0.0025
331 CYSTITIS 80 0.0025
332 CYTOMEGALOVIRUS VIRAEMIA 11 0.0025
333 GASTROINTESTINAL INFECTION 22 0.0025
334 FOOT FRACTURE 46 0.0024
335 ENTEROCOLITIS 14 0.0024
336 CHILLS 283 0.0024
337 GINGIVITIS 13 0.0024
338 INJECTION SITE INFLAMMATION 12 0.0024
339 SKIN INFECTION 27 0.0024
340 INJURY ASSOCIATED WITH DEVICE 49 0.0024
341 LYMPHADENOPATHY 85 0.0024
342 SKIN DISCOLOURATION 110 0.0024
343 RESPIRATORY TRACT CONGESTION 38 0.0024
344 FEAR OF INJECTION 17 0.0024
345 SKIN PLAQUE 20 0.0024
346 MOOD ALTERED 64 0.0023
347 SCAR 40 0.0023
348 FEELING COLD 65 0.0023
349 FEELING HOT 143 0.0023
350 SPUTUM DISCOLOURED 22 0.0023
351 DEPRESSED MOOD 122 0.0023
352 COUGH 646 0.0023
353 CELLULITIS 116 0.0023
354 SKIN LACERATION 25 0.0023
355 RESPIRATORY SYNCYTIAL VIRUS INFECTION 20 0.0023
356 RASH 998 0.0023
357 RASH VESICULAR 11 0.0023
358 MUSCULOSKELETAL STIFFNESS 197 0.0022
359 ORGANISING PNEUMONIA 11 0.0022
360 SPINAL PAIN 26 0.0022
361 GASTROENTERITIS VIRAL 40 0.0022
362 FEELING ABNORMAL 530 0.0022
363 INJECTION SITE REACTION 152 0.0022
364 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 106 0.0022
365 BACTERIAL INFECTION 41 0.0022
366 BURNING SENSATION 154 0.0022
367 MENTAL IMPAIRMENT 53 0.0022
368 MYOCARDITIS 25 0.0022
369 DISCOMFORT 133 0.0022
370 FEEDING DISORDER 44 0.0022
371 ARTHROPOD BITE 16 0.0022
372 STREPTOCOCCAL INFECTION 12 0.0022
373 ENDOCARDITIS 11 0.0021
374 THROAT IRRITATION 96 0.0021
375 PULMONARY ALVEOLAR HAEMORRHAGE 12 0.0021
376 RIB FRACTURE 44 0.0021
377 HAND DEFORMITY 28 0.0021
378 FLANK PAIN 20 0.0021
379 OSTEONECROSIS 70 0.0021
380 INCORRECT DOSE ADMINISTERED 486 0.0021
381 CHEST DISCOMFORT 218 0.0021
382 IMPAIRED WORK ABILITY 45 0.0021
383 CHOLECYSTECTOMY 24 0.0021
384 INJECTION SITE DISCOMFORT 22 0.0021
385 PHARYNGEAL OEDEMA 32 0.0021
386 SUICIDAL IDEATION 190 0.0021
387 INJECTION SITE SWELLING 159 0.0021
388 DIVERTICULITIS 57 0.0021
389 NEURALGIA 50 0.0021
390 MATERNAL EXPOSURE BEFORE PREGNANCY 14 0.0020
391 ORAL DISORDER 15 0.0020
392 COLD SWEAT 36 0.0020
393 PRODUCT USE IN UNAPPROVED INDICATION 506 0.0020
394 INFLUENZA LIKE ILLNESS 168 0.0020
395 PRODUCT COMMUNICATION ISSUE 18 0.0020
396 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
397 LABORATORY TEST ABNORMAL 60 0.0020
398 RASH ERYTHEMATOUS 97 0.0020
399 TREATMENT FAILURE 168 0.0020
400 HYPERVOLAEMIA 10 0.0020
401 LIMB DISCOMFORT 62 0.0020
402 INJECTION SITE URTICARIA 49 0.0020
403 BLOOD DISORDER 16 0.0020
404 LUNG INFECTION 31 0.0020
405 STOMATITIS 121 0.0020
406 PRURITUS GENERALISED 43 0.0020
407 INSOMNIA 527 0.0020
408 NECROSIS 11 0.0020
409 MUSCULOSKELETAL DISCOMFORT 34 0.0020
410 ORAL CANDIDIASIS 26 0.0020
411 PRODUCT USE COMPLAINT 31 0.0020
412 ALOPECIA 386 0.0020
413 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 36 0.0020
414 THROAT TIGHTNESS 53 0.0020
415 INCREASED UPPER AIRWAY SECRETION 10 0.0019
416 INJECTION SITE EXTRAVASATION 24 0.0019
417 ESCHERICHIA INFECTION 16 0.0019
418 POST-TRAUMATIC STRESS DISORDER 13 0.0019
419 BREAST MASS 13 0.0019
420 DERMATITIS BULLOUS 14 0.0019
421 HYPOALBUMINAEMIA 15 0.0019
422 DYSURIA 71 0.0019
423 HYPERSENSITIVITY 358 0.0019
424 NAUSEA 1526 0.0019
425 LIGAMENT SPRAIN 19 0.0019
426 SECRETION DISCHARGE 24 0.0019
427 UTERINE LEIOMYOMA 14 0.0019
428 CORONARY ARTERY BYPASS 11 0.0019
429 URTICARIA 318 0.0019
430 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
431 SENSITIVE SKIN 14 0.0019
432 HAEMOLYTIC ANAEMIA 17 0.0019
433 NECK PAIN 106 0.0019
434 SCRATCH 20 0.0019
435 PERIPHERAL COLDNESS 26 0.0019
436 FURUNCLE 15 0.0019
437 FEELING DRUNK 14 0.0019
438 MYALGIA 320 0.0019
439 STAPHYLOCOCCAL INFECTION 62 0.0019
440 FOOD POISONING 10 0.0019
441 FUNGAL INFECTION 62 0.0019
442 MYASTHENIA GRAVIS 15 0.0019
443 LUNG DISORDER 91 0.0019
444 PAROSMIA 14 0.0019
445 EAR DISCOMFORT 19 0.0018
446 CHEILITIS 10 0.0018
447 BLOOD URINE PRESENT 35 0.0018
448 LIMB INJURY 50 0.0018
449 PRODUCT DISPENSING ERROR 40 0.0018
450 CANDIDA INFECTION 31 0.0018
451 PNEUMONIA 594 0.0018
452 THERMAL BURN 13 0.0018
453 NIGHT SWEATS 59 0.0018
454 PRODUCT ADMINISTRATION ERROR 37 0.0018
455 DYSPHONIA 107 0.0018
456 WOUND INFECTION 20 0.0018
457 HYPERAESTHESIA 15 0.0018
458 BRONCHOSPASM 26 0.0018
459 MUSCULOSKELETAL PAIN 95 0.0018
460 FOETAL GROWTH RESTRICTION 11 0.0018
461 THERAPEUTIC RESPONSE SHORTENED 60 0.0018
462 SKIN MASS 12 0.0018
463 FACE OEDEMA 30 0.0018
464 WRONG PRODUCT ADMINISTERED 12 0.0018
465 RESPIRATORY DISORDER 53 0.0018
466 POOR QUALITY SLEEP 38 0.0018
467 PSYCHIATRIC SYMPTOM 13 0.0018
468 PANIC ATTACK 64 0.0018
469 PHOTOPHOBIA 33 0.0018
470 MICTURITION URGENCY 20 0.0017
471 WEIGHT INCREASED 392 0.0017
472 VITAMIN D DEFICIENCY 17 0.0017
473 RASH PAPULAR 39 0.0017
474 MOBILITY DECREASED 125 0.0017
475 UROSEPSIS 16 0.0017
476 HYPERVENTILATION 10 0.0017
477 BONE PAIN 101 0.0017
478 TOOTH FRACTURE 19 0.0017
479 POST PROCEDURAL INFECTION 14 0.0017
480 SEPSIS 192 0.0017
481 ENTERITIS 11 0.0017
482 RASH PRURITIC 93 0.0017
483 TOOTHACHE 31 0.0017
484 BLISTER 96 0.0017
485 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
486 PREMATURE DELIVERY 27 0.0017
487 PROCEDURAL COMPLICATION 13 0.0017
488 HAND FRACTURE 12 0.0017
489 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
490 DIFFUSE LARGE B-CELL LYMPHOMA 13 0.0017
491 EMBOLISM 14 0.0017
492 INJECTION SITE ERYTHEMA 209 0.0017
493 MOVEMENT DISORDER 54 0.0017
494 DRUG EFFECT INCOMPLETE 61 0.0017
495 EXTRA DOSE ADMINISTERED 68 0.0017
496 ASPERGILLUS INFECTION 11 0.0017
497 HYPERLIPIDAEMIA 20 0.0017
498 ARTHROPATHY 93 0.0017
499 DERMATITIS ALLERGIC 21 0.0017
500 AGRANULOCYTOSIS 31 0.0017
501 RASH MACULAR 58 0.0017
502 INITIAL INSOMNIA 17 0.0017
503 GASTROINTESTINAL DISORDER 147 0.0016
504 SWOLLEN TONGUE 51 0.0016
505 FOETAL EXPOSURE DURING PREGNANCY 132 0.0016
506 DERMATITIS 34 0.0016
507 CEREBRAL DISORDER 12 0.0016
508 ERYTHEMA 333 0.0016
509 GAIT INABILITY 54 0.0016
510 BLOOD PRESSURE INCREASED 247 0.0016
511 IMPAIRED GASTRIC EMPTYING 22 0.0016
512 STENT PLACEMENT 13 0.0016
513 BLOOD PRESSURE DECREASED 107 0.0016
514 NODULE 21 0.0016
515 INFARCTION 11 0.0016
516 PRODUCT PREPARATION ERROR 33 0.0016
517 THERAPY PARTIAL RESPONDER 25 0.0016
518 INCORRECT DOSE ADMINISTERED BY DEVICE 42 0.0016
519 PANCREATITIS ACUTE 36 0.0016
520 BLOOD POTASSIUM INCREASED 26 0.0016
521 OVARIAN CYST 16 0.0016
522 INJECTION SITE MASS 59 0.0016
523 ANAPHYLACTIC REACTION 88 0.0016
524 ANXIETY 452 0.0016
525 OSTEOPOROSIS 65 0.0016
526 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
527 MUSCULOSKELETAL DISORDER 30 0.0016
528 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
529 EYE INFLAMMATION 15 0.0016
530 INJECTION SITE IRRITATION 20 0.0016
531 SLUGGISHNESS 16 0.0016
532 WEIGHT DECREASED 436 0.0016
533 SNEEZING 35 0.0016
534 MYOSITIS 14 0.0016
535 APHASIA 47 0.0016
536 DISEASE RECURRENCE 74 0.0016
537 NERVOUSNESS 81 0.0015
538 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 85 0.0015
539 PERITONITIS 32 0.0015
540 PULMONARY MASS 23 0.0015
541 HERPES SIMPLEX 10 0.0015
542 INJECTION SITE PRURITUS 103 0.0015
543 GENERALISED OEDEMA 19 0.0015
544 CYST 19 0.0015
545 MEMORY IMPAIRMENT 210 0.0015
546 PREMATURE BABY 46 0.0015
547 PANIC REACTION 11 0.0015
548 HYPOKINESIA 22 0.0015
549 POLLAKIURIA 63 0.0015
550 INTERVERTEBRAL DISC PROTRUSION 33 0.0015
551 AMNESIA 98 0.0015
552 RASH GENERALISED 39 0.0015
553 WHITE BLOOD CELL COUNT DECREASED 162 0.0015
554 IMPAIRED HEALING 49 0.0015
555 SPEECH DISORDER 78 0.0015
556 ABORTION INDUCED 14 0.0015
557 MUSCULOSKELETAL CHEST PAIN 23 0.0015
558 PRURITUS 571 0.0015
559 NERVOUS SYSTEM DISORDER 46 0.0015
560 BLOOD CREATININE INCREASED 96 0.0015
561 HYPOAESTHESIA 218 0.0015
562 ASTHENIA 546 0.0015
563 JOINT INJURY 31 0.0014
564 SEPTIC SHOCK 63 0.0014
565 ENCEPHALITIS 10 0.0014
566 ABSCESS 23 0.0014
567 PULMONARY CONGESTION 19 0.0014
568 HYPERTRANSAMINASAEMIA 10 0.0014
569 AUTOIMMUNE HEPATITIS 10 0.0014
570 ATRIAL SEPTAL DEFECT 12 0.0014
571 TRANSFUSION 15 0.0014
572 INCORRECT PRODUCT ADMINISTRATION DURATION 31 0.0014
573 ORAL PAIN 32 0.0014
574 THERAPY NON-RESPONDER 64 0.0014
575 LYMPHOMA 22 0.0014
576 INFUSION SITE ERYTHEMA 12 0.0014
577 ANKLE FRACTURE 22 0.0014
578 BACK PAIN 330 0.0014
579 SEIZURE 164 0.0014
580 MALIGNANT MELANOMA 19 0.0014
581 BLADDER DISORDER 14 0.0014
582 DIALYSIS 20 0.0014
583 DRUG INEFFECTIVE 1857 0.0014
584 NERVE COMPRESSION 13 0.0014
585 LOWER RESPIRATORY TRACT INFECTION 64 0.0014
586 RENAL IMPAIRMENT 118 0.0014
587 DERMATITIS CONTACT 16 0.0014
588 SCAB 16 0.0014
589 BALANCE DISORDER 121 0.0014
590 HEREDITARY ANGIOEDEMA 15 0.0014
591 FLUID RETENTION 71 0.0014
592 EMOTIONAL DISORDER 43 0.0014
593 NEPHROPATHY 13 0.0014
594 PRODUCT PRESCRIBING ERROR 33 0.0014
595 OSTEOPENIA 21 0.0014
596 DRY EYE 69 0.0014
597 BIPOLAR DISORDER 15 0.0014
598 BACK INJURY 15 0.0014
599 DRY THROAT 14 0.0014
600 COLITIS 52 0.0014
601 APATHY 20 0.0014
602 BLOOD POTASSIUM DECREASED 41 0.0014
603 GASTROINTESTINAL PAIN 15 0.0014
604 SINUS DISORDER 27 0.0014
605 BLINDNESS TRANSIENT 10 0.0014
606 MENTAL DISORDER 59 0.0014
607 AFFECT LABILITY 13 0.0013
608 BLINDNESS 55 0.0013
609 NERVE INJURY 15 0.0013
610 ATELECTASIS 13 0.0013
611 PETECHIAE 14 0.0013
612 DRUG ADMINISTRATION ERROR 41 0.0013
613 DISTURBANCE IN ATTENTION 72 0.0013
614 SYNOVITIS 24 0.0013
615 THYROID CANCER 16 0.0013
616 DIZZINESS 663 0.0013
617 MENSTRUAL DISORDER 11 0.0013
618 HYPOAESTHESIA ORAL 20 0.0013
619 OSTEOMYELITIS 24 0.0013
620 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 94 0.0013
621 ADRENAL INSUFFICIENCY 16 0.0013
622 FEELING JITTERY 25 0.0013
623 SENSATION OF FOREIGN BODY 11 0.0013
624 RHEUMATOID ARTHRITIS 148 0.0013
625 LOWER LIMB FRACTURE 25 0.0013
626 INTERCEPTED PRODUCT PREPARATION ERROR 16 0.0013
627 DECREASED ACTIVITY 14 0.0013
628 MUSCLE TIGHTNESS 21 0.0013
629 TENDON RUPTURE 16 0.0013
630 CONCUSSION 10 0.0013
631 VOMITING 605 0.0013
632 PULMONARY THROMBOSIS 14 0.0013
633 ABDOMINAL PAIN UPPER 264 0.0013
634 SKIN REACTION 18 0.0013
635 OFF LABEL USE 1118 0.0013
636 LACERATION 12 0.0013
637 MUSCULAR WEAKNESS 145 0.0013
638 ARTERIAL OCCLUSIVE DISEASE 10 0.0013
639 GAIT DISTURBANCE 243 0.0013
640 MUSCLE ATROPHY 16 0.0013
641 PAIN OF SKIN 34 0.0013
642 TEMPERATURE INTOLERANCE 13 0.0013
643 URINE OUTPUT DECREASED 11 0.0013
644 GASTRITIS 33 0.0013
645 DIARRHOEA 803 0.0012
646 ANOSMIA 18 0.0012
647 HEMIPARESIS 21 0.0012
648 PAIN IN JAW 35 0.0012
649 DEVICE RELATED INFECTION 19 0.0012
650 CYTOPENIA 15 0.0012
651 HEAVY MENSTRUAL BLEEDING 11 0.0012
652 MENORRHAGIA 24 0.0012
653 ANGINA PECTORIS 35 0.0012
654 PALPITATIONS 143 0.0012
655 ROAD TRAFFIC ACCIDENT 51 0.0012
656 BREAST PAIN 13 0.0012
657 CARDIOMYOPATHY 18 0.0012
658 SOMNOLENCE 245 0.0012
659 FRACTURE 23 0.0012
660 DYSPNOEA 684 0.0012
661 SKIN CANCER 26 0.0012
662 DRUG EFFECT DECREASED 65 0.0012
663 HYPERTENSION 255 0.0012
664 HEMIPLEGIA 10 0.0012
665 PULMONARY HYPERTENSION 25 0.0012
666 PNEUMOTHORAX 19 0.0012
667 HAIR TEXTURE ABNORMAL 16 0.0012
668 INCREASED TENDENCY TO BRUISE 11 0.0012
669 IRON DEFICIENCY ANAEMIA 11 0.0012
670 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
671 ASCITES 35 0.0012
672 FEAR 32 0.0012
673 HERNIA 23 0.0012
674 EYE DISORDER 39 0.0012
675 CONJUNCTIVITIS 22 0.0012
676 PERSONALITY CHANGE 11 0.0012
677 IMPAIRED QUALITY OF LIFE 17 0.0012
678 INJECTION SITE NODULE 13 0.0012
679 ERYTHEMA MULTIFORME 11 0.0012
680 NEUTROPENIA 160 0.0012
681 PALLOR 32 0.0012
682 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
683 FACIAL PARALYSIS 10 0.0012
684 BACK DISORDER 19 0.0012
685 HAEMATURIA 40 0.0012
686 INJECTION SITE WARMTH 24 0.0012
687 BLOOD PRESSURE FLUCTUATION 28 0.0012
688 IRRITABLE BOWEL SYNDROME 25 0.0012
689 LETHARGY 67 0.0012
690 TENDONITIS 18 0.0012
691 ADVERSE EVENT 107 0.0012
692 OCULAR DISCOMFORT 13 0.0012
693 THERAPEUTIC RESPONSE DECREASED 70 0.0012
694 BASAL CELL CARCINOMA 18 0.0012
695 TENDERNESS 12 0.0012
696 PSYCHOTIC DISORDER 34 0.0012
697 HEART RATE INCREASED 114 0.0011
698 SPINAL FRACTURE 23 0.0011
699 ARRHYTHMIA 54 0.0011
700 BLINDNESS UNILATERAL 16 0.0011
701 SCIATICA 18 0.0011
702 THROMBOTIC MICROANGIOPATHY 11 0.0011
703 RETCHING 24 0.0011
704 PRODUCT USE ISSUE 210 0.0011
705 CARDIAC DISORDER 104 0.0011
706 LIVER DISORDER 49 0.0011
707 THYROID DISORDER 17 0.0011
708 BRAIN INJURY 11 0.0011
709 DRY MOUTH 89 0.0011
710 TREATMENT NONCOMPLIANCE 60 0.0011
711 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
712 ANGER 37 0.0011
713 THROMBOSIS 88 0.0011
714 POST PROCEDURAL COMPLICATION 21 0.0011
715 BRAIN NEOPLASM 10 0.0011
716 WRIST FRACTURE 13 0.0011
717 AMENORRHOEA 19 0.0011
718 FOOT DEFORMITY 12 0.0011
719 INJECTION SITE INDURATION 14 0.0011
720 PANCREATITIS 57 0.0011
721 CATARACT 64 0.0011
722 ABDOMINAL DISCOMFORT 180 0.0011
723 THERAPEUTIC PRODUCT EFFECT DECREASED 48 0.0011
724 PLEURAL EFFUSION 65 0.0011
725 VERTIGO 65 0.0011
726 ABDOMINAL PAIN 248 0.0011
727 ARTERIOSCLEROSIS 10 0.0011
728 TREMOR 176 0.0011
729 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
730 LIVER INJURY 26 0.0011
731 HAEMATOCRIT DECREASED 21 0.0011
732 EYE DISCHARGE 11 0.0011
733 BLOOD PRESSURE ABNORMAL 21 0.0011
734 INTERNAL HAEMORRHAGE 12 0.0010
735 EYE HAEMORRHAGE 14 0.0010
736 SLEEP APNOEA SYNDROME 20 0.0010
737 NEOPLASM 12 0.0010
738 DYSPNOEA EXERTIONAL 39 0.0010
739 TOOTH DISORDER 23 0.0010
740 DEVICE USE ISSUE 18 0.0010
741 HEPATIC ENZYME INCREASED 70 0.0010
742 TACHYCARDIA 91 0.0010
743 COAGULOPATHY 17 0.0010
744 GASTRIC DISORDER 35 0.0010
745 LYMPHOCYTE COUNT DECREASED 18 0.0010
746 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
747 HEPATOMEGALY 10 0.0010
748 PARAESTHESIA 160 0.0010
749 OSTEOARTHRITIS 43 0.0010
750 OEDEMA 55 0.0010
751 FLUSHING 103 0.0010
752 DEHYDRATION 135 0.0010
753 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 72 0.0010
754 BLOOD IRON DECREASED 12 0.0010
755 ORAL DISCOMFORT 14 0.0010
756 COGNITIVE DISORDER 47 0.0010
757 GASTROOESOPHAGEAL REFLUX DISEASE 81 0.0010
758 PLATELET COUNT DECREASED 107 0.0010
759 HAEMATOMA 26 0.0010
760 GOUT 18 0.0010
761 PNEUMONIA ASPIRATION 25 0.0010
762 INCREASED APPETITE 19 0.0010
763 DEVICE LEAKAGE 43 0.0010
764 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
765 FALL 328 0.0010
766 PANCYTOPENIA 55 0.0010
767 MUSCLE SPASMS 180 0.0010
768 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
769 REBOUND EFFECT 11 0.0010
770 HYPERHIDROSIS 125 0.0010
771 CEREBROVASCULAR ACCIDENT 164 0.0010
772 IMPAIRED DRIVING ABILITY 11 0.0010
773 ABDOMINAL DISTENSION 101 0.0010
774 C-REACTIVE PROTEIN INCREASED 35 0.0010
775 OEDEMA PERIPHERAL 117 0.0010
776 PNEUMONITIS 26 0.0010
777 VISUAL IMPAIRMENT 118 0.0010
778 WHEEZING 56 0.0009
779 DECREASED APPETITE 219 0.0009
780 EYE SWELLING 35 0.0009
781 ACUTE RESPIRATORY FAILURE 18 0.0009
782 HUNGER 13 0.0009
783 COVID-19 PNEUMONIA 11 0.0009
784 BODY TEMPERATURE INCREASED 19 0.0009
785 CARPAL TUNNEL SYNDROME 13 0.0009
786 SKIN BURNING SENSATION 66 0.0009
787 SKIN FISSURES 18 0.0009
788 DIABETES MELLITUS 70 0.0009
789 THINKING ABNORMAL 17 0.0009
790 HYPOTHYROIDISM 29 0.0009
791 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
792 HEPATIC CIRRHOSIS 17 0.0009
793 PRESCRIBED UNDERDOSE 18 0.0009
794 CEREBRAL INFARCTION 22 0.0009
795 HEPATITIS 23 0.0009
796 JOINT RANGE OF MOTION DECREASED 12 0.0009
797 PULMONARY OEDEMA 40 0.0009
798 ANAPHYLACTIC SHOCK 23 0.0009
799 ABASIA 22 0.0009
800 HEAD INJURY 28 0.0009
801 NEOPLASM MALIGNANT 59 0.0009
802 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
803 DEAFNESS 23 0.0009
804 GINGIVAL BLEEDING 12 0.0009
805 SKIN HAEMORRHAGE 13 0.0009
806 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
807 COLON CANCER 13 0.0009
808 BRAIN OEDEMA 11 0.0009
809 DRUG INTOLERANCE 84 0.0009
810 DEVICE MALFUNCTION 61 0.0009
811 IRRITABILITY 52 0.0009
812 HEPATIC STEATOSIS 16 0.0009
813 LOSS OF CONSCIOUSNESS 110 0.0009
814 DEVICE FAILURE 13 0.0009
815 UPPER LIMB FRACTURE 17 0.0009
816 THROMBOCYTOPENIA 95 0.0008
817 SEASONAL ALLERGY 12 0.0008
818 AGEUSIA 21 0.0008
819 LIVER FUNCTION TEST INCREASED 18 0.0008
820 OXYGEN SATURATION DECREASED 47 0.0008
821 SLEEP DISORDER 59 0.0008
822 EYE PAIN 47 0.0008
823 MENTAL STATUS CHANGES 23 0.0008
824 PRESYNCOPE 20 0.0008
825 HYPOTENSION 164 0.0008
826 PARANOIA 14 0.0008
827 OVERDOSE 174 0.0008
828 ASTHMA 91 0.0008
829 ANAEMIA 153 0.0008
830 VISION BLURRED 110 0.0008
831 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
832 EATING DISORDER 17 0.0008
833 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
834 DRUG ERUPTION 14 0.0008
835 SYNCOPE 79 0.0008
836 PULMONARY EMBOLISM 75 0.0008
837 MASS 11 0.0008
838 PULMONARY FIBROSIS 15 0.0008
839 MUSCLE TWITCHING 18 0.0008
840 BREAST CANCER 72 0.0008
841 DIPLOPIA 20 0.0008
842 ANGIOEDEMA 34 0.0008
843 PARALYSIS 11 0.0008
844 BONE DISORDER 14 0.0008
845 RESPIRATORY FAILURE 56 0.0008
846 END STAGE RENAL DISEASE 14 0.0008
847 CYANOSIS 12 0.0008
848 TINNITUS 35 0.0008
849 HYPERTHYROIDISM 11 0.0008
850 DYSMENORRHOEA 10 0.0008
851 DYSGEUSIA 56 0.0008
852 MOOD SWINGS 24 0.0008
853 EPILEPSY 23 0.0008
854 ABDOMINAL PAIN LOWER 19 0.0008
855 HAEMORRHAGE 78 0.0007
856 INTENTIONAL SELF-INJURY 15 0.0007
857 OCULAR HYPERAEMIA 35 0.0007
858 CEREBRAL HAEMORRHAGE 26 0.0007
859 EPISTAXIS 54 0.0007
860 DYSSTASIA 21 0.0007
861 RESTLESS LEGS SYNDROME 13 0.0007
862 HYPOXIA 25 0.0007
863 HOT FLUSH 53 0.0007
864 CHOLELITHIASIS 23 0.0007
865 RENAL FAILURE 93 0.0007
866 CARDIOGENIC SHOCK 10 0.0007
867 NEUROPATHY PERIPHERAL 66 0.0007
868 NIGHTMARE 24 0.0007
869 CONFUSIONAL STATE 112 0.0007
870 RESPIRATORY DISTRESS 19 0.0007
871 SKIN EXFOLIATION 58 0.0007
872 MATERNAL EXPOSURE DURING PREGNANCY 61 0.0007
873 HIP FRACTURE 22 0.0007
874 DISORIENTATION 27 0.0007
875 CARDIAC ARREST 56 0.0007
876 CARDIAC FAILURE 54 0.0007
877 HAEMOGLOBIN DECREASED 69 0.0007
878 PRODUCT QUALITY ISSUE 90 0.0007
879 LIVER FUNCTION TEST ABNORMAL 19 0.0007
880 ENCEPHALOPATHY 16 0.0007
881 HAEMOPTYSIS 18 0.0006
882 MIDDLE INSOMNIA 12 0.0006
883 BONE MARROW FAILURE 13 0.0006
884 BREAST CANCER FEMALE 17 0.0006
885 DEVICE DEFECTIVE 11 0.0006
886 HAEMATEMESIS 16 0.0006
887 TRANSAMINASES INCREASED 14 0.0006
888 RED BLOOD CELL COUNT DECREASED 18 0.0006
889 LACRIMATION INCREASED 19 0.0006
890 GLOSSODYNIA 14 0.0006
891 MYOCARDIAL INFARCTION 109 0.0006
892 VAGINAL HAEMORRHAGE 27 0.0006
893 DEATH 534 0.0006
894 HEART RATE IRREGULAR 14 0.0006
895 GALLBLADDER DISORDER 11 0.0006
896 DEEP VEIN THROMBOSIS 40 0.0006
897 DYSPHAGIA 58 0.0006
898 ACUTE MYOCARDIAL INFARCTION 18 0.0006
899 LEUKOCYTOSIS 11 0.0006
900 VISUAL ACUITY REDUCED 20 0.0006
901 MENSTRUATION IRREGULAR 16 0.0006
902 SUICIDE ATTEMPT 36 0.0006
903 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 120 0.0006
904 DYSPEPSIA 58 0.0006
905 BLOOD CHOLESTEROL INCREASED 27 0.0006
906 CHROMATURIA 13 0.0006
907 URINARY RETENTION 19 0.0006
908 DRY SKIN 75 0.0006
909 INTESTINAL OBSTRUCTION 21 0.0006
910 GENERAL PHYSICAL HEALTH DETERIORATION 64 0.0006
911 FLATULENCE 31 0.0005
912 HYPOKALAEMIA 25 0.0005
913 BLOOD GLUCOSE ABNORMAL 10 0.0005
914 URINARY INCONTINENCE 16 0.0005
915 COLITIS ULCERATIVE 24 0.0005
916 ECZEMA 28 0.0005
917 DYSARTHRIA 20 0.0005
918 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
919 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
920 GASTRIC ULCER 10 0.0005
921 RESTLESSNESS 19 0.0005
922 FREQUENT BOWEL MOVEMENTS 14 0.0005
923 FEMUR FRACTURE 16 0.0005
924 NEEDLE ISSUE 15 0.0005
925 FEBRILE NEUTROPENIA 34 0.0005
926 CARDIOVASCULAR DISORDER 13 0.0005
927 HYPOACUSIS 22 0.0005
928 CARDIAC FAILURE CONGESTIVE 41 0.0005
929 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
930 SKIN IRRITATION 23 0.0005
931 ACNE 38 0.0005
932 INTERSTITIAL LUNG DISEASE 24 0.0005
933 STEVENS-JOHNSON SYNDROME 11 0.0005
934 NEUTROPHIL COUNT DECREASED 20 0.0005
935 AGITATION 36 0.0005
936 HYPERKALAEMIA 17 0.0005
937 EYE PRURITUS 16 0.0005
938 ABNORMAL DREAMS 13 0.0005
939 HYPERGLYCAEMIA 17 0.0005
940 FAECES DISCOLOURED 10 0.0005
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
942 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
943 BLOOD GLUCOSE DECREASED 21 0.0004
944 INTENTIONAL PRODUCT MISUSE 38 0.0004
945 CONSTIPATION 94 0.0004
946 HYPOPHAGIA 11 0.0004
947 AGGRESSION 21 0.0004
948 WITHDRAWAL SYNDROME 17 0.0004
949 ABNORMAL BEHAVIOUR 16 0.0004
950 DELIRIUM 14 0.0004
951 ATRIAL FIBRILLATION 39 0.0004
952 EYE IRRITATION 23 0.0004
953 HEART RATE DECREASED 14 0.0004
954 PROCEDURAL PAIN 11 0.0004
955 HYPOGLYCAEMIA 19 0.0004
956 LUNG NEOPLASM MALIGNANT 16 0.0004
957 DISEASE PROGRESSION 46 0.0004
958 HAEMATOCHEZIA 21 0.0004
959 COMA 18 0.0004
960 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
961 ACUTE KIDNEY INJURY 56 0.0004
962 DEVICE DELIVERY SYSTEM ISSUE 10 0.0004
963 MYELOSUPPRESSION 13 0.0004
964 DRUG-INDUCED LIVER INJURY 11 0.0004
965 CONVULSION 20 0.0003
966 PSORIATIC ARTHROPATHY 14 0.0003
967 DYSKINESIA 14 0.0003
968 METABOLIC ACIDOSIS 11 0.0003
969 UNEVALUABLE EVENT 26 0.0003
970 BLOOD GLUCOSE INCREASED 63 0.0003
971 HEPATIC FAILURE 10 0.0003
972 HEPATIC FUNCTION ABNORMAL 12 0.0003
973 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
974 HALLUCINATION 24 0.0003
975 BRADYCARDIA 16 0.0003
976 EXPIRED PRODUCT ADMINISTERED 10 0.0003
977 PSORIASIS 39 0.0003
978 EMOTIONAL DISTRESS 35 0.0003
979 INJURY 20 0.0003
980 NO ADVERSE EVENT 51 0.0003
981 DEVICE DIFFICULT TO USE 18 0.0003
982 CHRONIC KIDNEY DISEASE 20 0.0003
983 MEDICATION ERROR 14 0.0003
984 DRUG INTERACTION 38 0.0002
985 PRODUCT SUBSTITUTION ISSUE 13 0.0002
986 DEVICE ISSUE 20 0.0002
987 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
988 TOXICITY TO VARIOUS AGENTS 22 0.0001
989 DRUG DEPENDENCE 20 0.0001